Loading…

Fibroblastic reticular cells mitigate acute GvHD via MHCII-dependent maintenance of regulatory T cells

Acute graft versus host disease (aGvHD) is a life-threatening complication of allogeneic hematopoietic cell transplantation (allo-HCT) inflicted by alloreactive T cells primed in secondary lymphoid organs (SLOs) and subsequent damage to aGvHD target tissues. In recent years, Treg transfer and/or exp...

Full description

Saved in:
Bibliographic Details
Published in:JCI insight 2022-11, Vol.7 (22)
Main Authors: Shaikh, Haroon, Pezoldt, Joern, Mokhtari, Zeinab, Gamboa Vargas, Juan, Le, Duc-Dung, Peña Mosca, Josefina, Arellano Viera, Estibaliz, Kern, Michael Ag, Graf, Caroline, Beyersdorf, Niklas, Lutz, Manfred B, Riedel, Angela, Büttner-Herold, Maike, Zernecke, Alma, Einsele, Hermann, Saliba, Antoine-Emmanuel, Ludewig, Burkhard, Huehn, Jochen, Beilhack, Andreas
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c468t-ca5c2d5d69c137ddcadfaca406fb265a546d7b846837fa6b11688b3afe6b026b3
cites cdi_FETCH-LOGICAL-c468t-ca5c2d5d69c137ddcadfaca406fb265a546d7b846837fa6b11688b3afe6b026b3
container_end_page
container_issue 22
container_start_page
container_title JCI insight
container_volume 7
creator Shaikh, Haroon
Pezoldt, Joern
Mokhtari, Zeinab
Gamboa Vargas, Juan
Le, Duc-Dung
Peña Mosca, Josefina
Arellano Viera, Estibaliz
Kern, Michael Ag
Graf, Caroline
Beyersdorf, Niklas
Lutz, Manfred B
Riedel, Angela
Büttner-Herold, Maike
Zernecke, Alma
Einsele, Hermann
Saliba, Antoine-Emmanuel
Ludewig, Burkhard
Huehn, Jochen
Beilhack, Andreas
description Acute graft versus host disease (aGvHD) is a life-threatening complication of allogeneic hematopoietic cell transplantation (allo-HCT) inflicted by alloreactive T cells primed in secondary lymphoid organs (SLOs) and subsequent damage to aGvHD target tissues. In recent years, Treg transfer and/or expansion has emerged as a promising therapy to modulate aGvHD. However, cellular niches essential for fostering Tregs to prevent aGvHD have not been explored. Here, we tested whether and to what extent MHC class II (MHCII) expressed on Ccl19+ fibroblastic reticular cells (FRCs) shape the donor CD4+ T cell response during aGvHD. Animals lacking MHCII expression on Ccl19-Cre-expressing FRCs (MHCIIΔCcl19) showed aberrant CD4+ T cell activation in the effector phase, resulting in exacerbated aGvHD that was associated with significantly reduced expansion of Foxp3+ Tregs and invariant NK T (iNKT) cells. Skewed Treg maintenance in MHCIIΔCcl19 mice resulted in loss of protection from aGvHD provided by adoptively transferred donor Tregs. In contrast, although FRCs upregulated costimulatory surface receptors, and although they degraded and processed exogenous antigens after myeloablative irradiation, FRCs were dispensable to activate alloreactive CD4+ T cells in 2 mouse models of aGvHD. In summary, these data reveal an immunoprotective, MHCII-mediated function of FRC niches in secondary lymphoid organs (SLOs) after allo-HCT and highlight a framework of cellular and molecular interactions that regulate CD4+ T cell alloimmunity.
doi_str_mv 10.1172/jci.insight.154250
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_611e9d7a43884ebd9ad1480c9f61f8b7</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_611e9d7a43884ebd9ad1480c9f61f8b7</doaj_id><sourcerecordid>2724581762</sourcerecordid><originalsourceid>FETCH-LOGICAL-c468t-ca5c2d5d69c137ddcadfaca406fb265a546d7b846837fa6b11688b3afe6b026b3</originalsourceid><addsrcrecordid>eNpVkU1v1DAQhiMEolXpH-CAcuSSxV-xnQsSWmh3pSIu5WyNv1Kvknixk5X673HJUrWXGcvzzuMZv1X1EaMNxoJ8OZiwCVMO_cO8wS0jLXpTXRIquoYKJN--OF9U1zkfEEJYMIJa-b66oJwQwaW4rPxN0CnqAfIcTJ1cicsAqTZuGHI9hjn0MLsazFLi7Wn3vT4FqH_utvt9Y93RTdZNcz1CmGY3wWRcHX3B9AUyx_RY36-kD9U7D0N21-d8Vf2--XG_3TV3v2732293jWFczo2B1hDbWt4ZTIW1BqwHAwxxrwlvoWXcCi2LlgoPXGPMpdQUvOMaEa7pVbVfuTbCQR1TGCE9qghB_buIqVeQyo6DUxxj11kBjErJnLYdWMwkMp3n2EstCuvryjouenTWlEUTDK-grytTeFB9PKlOlAEJKoDPZ0CKfxaXZzWG_PQdMLm4ZEUEYa3EgpMiJavUpJhzcv75GYzUk9-q-K3OfqvV79L06eWAzy3_3aV_ARFJq7E</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2724581762</pqid></control><display><type>article</type><title>Fibroblastic reticular cells mitigate acute GvHD via MHCII-dependent maintenance of regulatory T cells</title><source>PubMed Central</source><creator>Shaikh, Haroon ; Pezoldt, Joern ; Mokhtari, Zeinab ; Gamboa Vargas, Juan ; Le, Duc-Dung ; Peña Mosca, Josefina ; Arellano Viera, Estibaliz ; Kern, Michael Ag ; Graf, Caroline ; Beyersdorf, Niklas ; Lutz, Manfred B ; Riedel, Angela ; Büttner-Herold, Maike ; Zernecke, Alma ; Einsele, Hermann ; Saliba, Antoine-Emmanuel ; Ludewig, Burkhard ; Huehn, Jochen ; Beilhack, Andreas</creator><creatorcontrib>Shaikh, Haroon ; Pezoldt, Joern ; Mokhtari, Zeinab ; Gamboa Vargas, Juan ; Le, Duc-Dung ; Peña Mosca, Josefina ; Arellano Viera, Estibaliz ; Kern, Michael Ag ; Graf, Caroline ; Beyersdorf, Niklas ; Lutz, Manfred B ; Riedel, Angela ; Büttner-Herold, Maike ; Zernecke, Alma ; Einsele, Hermann ; Saliba, Antoine-Emmanuel ; Ludewig, Burkhard ; Huehn, Jochen ; Beilhack, Andreas</creatorcontrib><description>Acute graft versus host disease (aGvHD) is a life-threatening complication of allogeneic hematopoietic cell transplantation (allo-HCT) inflicted by alloreactive T cells primed in secondary lymphoid organs (SLOs) and subsequent damage to aGvHD target tissues. In recent years, Treg transfer and/or expansion has emerged as a promising therapy to modulate aGvHD. However, cellular niches essential for fostering Tregs to prevent aGvHD have not been explored. Here, we tested whether and to what extent MHC class II (MHCII) expressed on Ccl19+ fibroblastic reticular cells (FRCs) shape the donor CD4+ T cell response during aGvHD. Animals lacking MHCII expression on Ccl19-Cre-expressing FRCs (MHCIIΔCcl19) showed aberrant CD4+ T cell activation in the effector phase, resulting in exacerbated aGvHD that was associated with significantly reduced expansion of Foxp3+ Tregs and invariant NK T (iNKT) cells. Skewed Treg maintenance in MHCIIΔCcl19 mice resulted in loss of protection from aGvHD provided by adoptively transferred donor Tregs. In contrast, although FRCs upregulated costimulatory surface receptors, and although they degraded and processed exogenous antigens after myeloablative irradiation, FRCs were dispensable to activate alloreactive CD4+ T cells in 2 mouse models of aGvHD. In summary, these data reveal an immunoprotective, MHCII-mediated function of FRC niches in secondary lymphoid organs (SLOs) after allo-HCT and highlight a framework of cellular and molecular interactions that regulate CD4+ T cell alloimmunity.</description><identifier>ISSN: 2379-3708</identifier><identifier>EISSN: 2379-3708</identifier><identifier>DOI: 10.1172/jci.insight.154250</identifier><identifier>PMID: 36227687</identifier><language>eng</language><publisher>United States: American Society for Clinical Investigation</publisher><subject>Animals ; Graft vs Host Disease - prevention &amp; control ; Hematology ; Hematopoietic Stem Cell Transplantation - methods ; Mice ; Mice, Inbred BALB C ; Mice, Inbred C57BL ; T-Lymphocytes, Regulatory ; Transplantation</subject><ispartof>JCI insight, 2022-11, Vol.7 (22)</ispartof><rights>2022 Shaikh et al. 2022 Shaikh et al.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c468t-ca5c2d5d69c137ddcadfaca406fb265a546d7b846837fa6b11688b3afe6b026b3</citedby><cites>FETCH-LOGICAL-c468t-ca5c2d5d69c137ddcadfaca406fb265a546d7b846837fa6b11688b3afe6b026b3</cites><orcidid>0000-0001-5257-4776 ; 0000-0001-8551-4729 ; 0000-0002-7680-0819 ; 0000-0001-9193-1772 ; 0000-0001-7143-5691 ; 0000-0001-8071-1379 ; 0000-0002-3165-2648 ; 0000-0002-1954-3641</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746820/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746820/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,724,777,781,882,27905,27906,53772,53774</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36227687$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Shaikh, Haroon</creatorcontrib><creatorcontrib>Pezoldt, Joern</creatorcontrib><creatorcontrib>Mokhtari, Zeinab</creatorcontrib><creatorcontrib>Gamboa Vargas, Juan</creatorcontrib><creatorcontrib>Le, Duc-Dung</creatorcontrib><creatorcontrib>Peña Mosca, Josefina</creatorcontrib><creatorcontrib>Arellano Viera, Estibaliz</creatorcontrib><creatorcontrib>Kern, Michael Ag</creatorcontrib><creatorcontrib>Graf, Caroline</creatorcontrib><creatorcontrib>Beyersdorf, Niklas</creatorcontrib><creatorcontrib>Lutz, Manfred B</creatorcontrib><creatorcontrib>Riedel, Angela</creatorcontrib><creatorcontrib>Büttner-Herold, Maike</creatorcontrib><creatorcontrib>Zernecke, Alma</creatorcontrib><creatorcontrib>Einsele, Hermann</creatorcontrib><creatorcontrib>Saliba, Antoine-Emmanuel</creatorcontrib><creatorcontrib>Ludewig, Burkhard</creatorcontrib><creatorcontrib>Huehn, Jochen</creatorcontrib><creatorcontrib>Beilhack, Andreas</creatorcontrib><title>Fibroblastic reticular cells mitigate acute GvHD via MHCII-dependent maintenance of regulatory T cells</title><title>JCI insight</title><addtitle>JCI Insight</addtitle><description>Acute graft versus host disease (aGvHD) is a life-threatening complication of allogeneic hematopoietic cell transplantation (allo-HCT) inflicted by alloreactive T cells primed in secondary lymphoid organs (SLOs) and subsequent damage to aGvHD target tissues. In recent years, Treg transfer and/or expansion has emerged as a promising therapy to modulate aGvHD. However, cellular niches essential for fostering Tregs to prevent aGvHD have not been explored. Here, we tested whether and to what extent MHC class II (MHCII) expressed on Ccl19+ fibroblastic reticular cells (FRCs) shape the donor CD4+ T cell response during aGvHD. Animals lacking MHCII expression on Ccl19-Cre-expressing FRCs (MHCIIΔCcl19) showed aberrant CD4+ T cell activation in the effector phase, resulting in exacerbated aGvHD that was associated with significantly reduced expansion of Foxp3+ Tregs and invariant NK T (iNKT) cells. Skewed Treg maintenance in MHCIIΔCcl19 mice resulted in loss of protection from aGvHD provided by adoptively transferred donor Tregs. In contrast, although FRCs upregulated costimulatory surface receptors, and although they degraded and processed exogenous antigens after myeloablative irradiation, FRCs were dispensable to activate alloreactive CD4+ T cells in 2 mouse models of aGvHD. In summary, these data reveal an immunoprotective, MHCII-mediated function of FRC niches in secondary lymphoid organs (SLOs) after allo-HCT and highlight a framework of cellular and molecular interactions that regulate CD4+ T cell alloimmunity.</description><subject>Animals</subject><subject>Graft vs Host Disease - prevention &amp; control</subject><subject>Hematology</subject><subject>Hematopoietic Stem Cell Transplantation - methods</subject><subject>Mice</subject><subject>Mice, Inbred BALB C</subject><subject>Mice, Inbred C57BL</subject><subject>T-Lymphocytes, Regulatory</subject><subject>Transplantation</subject><issn>2379-3708</issn><issn>2379-3708</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNpVkU1v1DAQhiMEolXpH-CAcuSSxV-xnQsSWmh3pSIu5WyNv1Kvknixk5X673HJUrWXGcvzzuMZv1X1EaMNxoJ8OZiwCVMO_cO8wS0jLXpTXRIquoYKJN--OF9U1zkfEEJYMIJa-b66oJwQwaW4rPxN0CnqAfIcTJ1cicsAqTZuGHI9hjn0MLsazFLi7Wn3vT4FqH_utvt9Y93RTdZNcz1CmGY3wWRcHX3B9AUyx_RY36-kD9U7D0N21-d8Vf2--XG_3TV3v2732293jWFczo2B1hDbWt4ZTIW1BqwHAwxxrwlvoWXcCi2LlgoPXGPMpdQUvOMaEa7pVbVfuTbCQR1TGCE9qghB_buIqVeQyo6DUxxj11kBjErJnLYdWMwkMp3n2EstCuvryjouenTWlEUTDK-grytTeFB9PKlOlAEJKoDPZ0CKfxaXZzWG_PQdMLm4ZEUEYa3EgpMiJavUpJhzcv75GYzUk9-q-K3OfqvV79L06eWAzy3_3aV_ARFJq7E</recordid><startdate>20221122</startdate><enddate>20221122</enddate><creator>Shaikh, Haroon</creator><creator>Pezoldt, Joern</creator><creator>Mokhtari, Zeinab</creator><creator>Gamboa Vargas, Juan</creator><creator>Le, Duc-Dung</creator><creator>Peña Mosca, Josefina</creator><creator>Arellano Viera, Estibaliz</creator><creator>Kern, Michael Ag</creator><creator>Graf, Caroline</creator><creator>Beyersdorf, Niklas</creator><creator>Lutz, Manfred B</creator><creator>Riedel, Angela</creator><creator>Büttner-Herold, Maike</creator><creator>Zernecke, Alma</creator><creator>Einsele, Hermann</creator><creator>Saliba, Antoine-Emmanuel</creator><creator>Ludewig, Burkhard</creator><creator>Huehn, Jochen</creator><creator>Beilhack, Andreas</creator><general>American Society for Clinical Investigation</general><general>American Society for Clinical investigation</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0001-5257-4776</orcidid><orcidid>https://orcid.org/0000-0001-8551-4729</orcidid><orcidid>https://orcid.org/0000-0002-7680-0819</orcidid><orcidid>https://orcid.org/0000-0001-9193-1772</orcidid><orcidid>https://orcid.org/0000-0001-7143-5691</orcidid><orcidid>https://orcid.org/0000-0001-8071-1379</orcidid><orcidid>https://orcid.org/0000-0002-3165-2648</orcidid><orcidid>https://orcid.org/0000-0002-1954-3641</orcidid></search><sort><creationdate>20221122</creationdate><title>Fibroblastic reticular cells mitigate acute GvHD via MHCII-dependent maintenance of regulatory T cells</title><author>Shaikh, Haroon ; Pezoldt, Joern ; Mokhtari, Zeinab ; Gamboa Vargas, Juan ; Le, Duc-Dung ; Peña Mosca, Josefina ; Arellano Viera, Estibaliz ; Kern, Michael Ag ; Graf, Caroline ; Beyersdorf, Niklas ; Lutz, Manfred B ; Riedel, Angela ; Büttner-Herold, Maike ; Zernecke, Alma ; Einsele, Hermann ; Saliba, Antoine-Emmanuel ; Ludewig, Burkhard ; Huehn, Jochen ; Beilhack, Andreas</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c468t-ca5c2d5d69c137ddcadfaca406fb265a546d7b846837fa6b11688b3afe6b026b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Animals</topic><topic>Graft vs Host Disease - prevention &amp; control</topic><topic>Hematology</topic><topic>Hematopoietic Stem Cell Transplantation - methods</topic><topic>Mice</topic><topic>Mice, Inbred BALB C</topic><topic>Mice, Inbred C57BL</topic><topic>T-Lymphocytes, Regulatory</topic><topic>Transplantation</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Shaikh, Haroon</creatorcontrib><creatorcontrib>Pezoldt, Joern</creatorcontrib><creatorcontrib>Mokhtari, Zeinab</creatorcontrib><creatorcontrib>Gamboa Vargas, Juan</creatorcontrib><creatorcontrib>Le, Duc-Dung</creatorcontrib><creatorcontrib>Peña Mosca, Josefina</creatorcontrib><creatorcontrib>Arellano Viera, Estibaliz</creatorcontrib><creatorcontrib>Kern, Michael Ag</creatorcontrib><creatorcontrib>Graf, Caroline</creatorcontrib><creatorcontrib>Beyersdorf, Niklas</creatorcontrib><creatorcontrib>Lutz, Manfred B</creatorcontrib><creatorcontrib>Riedel, Angela</creatorcontrib><creatorcontrib>Büttner-Herold, Maike</creatorcontrib><creatorcontrib>Zernecke, Alma</creatorcontrib><creatorcontrib>Einsele, Hermann</creatorcontrib><creatorcontrib>Saliba, Antoine-Emmanuel</creatorcontrib><creatorcontrib>Ludewig, Burkhard</creatorcontrib><creatorcontrib>Huehn, Jochen</creatorcontrib><creatorcontrib>Beilhack, Andreas</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>JCI insight</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Shaikh, Haroon</au><au>Pezoldt, Joern</au><au>Mokhtari, Zeinab</au><au>Gamboa Vargas, Juan</au><au>Le, Duc-Dung</au><au>Peña Mosca, Josefina</au><au>Arellano Viera, Estibaliz</au><au>Kern, Michael Ag</au><au>Graf, Caroline</au><au>Beyersdorf, Niklas</au><au>Lutz, Manfred B</au><au>Riedel, Angela</au><au>Büttner-Herold, Maike</au><au>Zernecke, Alma</au><au>Einsele, Hermann</au><au>Saliba, Antoine-Emmanuel</au><au>Ludewig, Burkhard</au><au>Huehn, Jochen</au><au>Beilhack, Andreas</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Fibroblastic reticular cells mitigate acute GvHD via MHCII-dependent maintenance of regulatory T cells</atitle><jtitle>JCI insight</jtitle><addtitle>JCI Insight</addtitle><date>2022-11-22</date><risdate>2022</risdate><volume>7</volume><issue>22</issue><issn>2379-3708</issn><eissn>2379-3708</eissn><abstract>Acute graft versus host disease (aGvHD) is a life-threatening complication of allogeneic hematopoietic cell transplantation (allo-HCT) inflicted by alloreactive T cells primed in secondary lymphoid organs (SLOs) and subsequent damage to aGvHD target tissues. In recent years, Treg transfer and/or expansion has emerged as a promising therapy to modulate aGvHD. However, cellular niches essential for fostering Tregs to prevent aGvHD have not been explored. Here, we tested whether and to what extent MHC class II (MHCII) expressed on Ccl19+ fibroblastic reticular cells (FRCs) shape the donor CD4+ T cell response during aGvHD. Animals lacking MHCII expression on Ccl19-Cre-expressing FRCs (MHCIIΔCcl19) showed aberrant CD4+ T cell activation in the effector phase, resulting in exacerbated aGvHD that was associated with significantly reduced expansion of Foxp3+ Tregs and invariant NK T (iNKT) cells. Skewed Treg maintenance in MHCIIΔCcl19 mice resulted in loss of protection from aGvHD provided by adoptively transferred donor Tregs. In contrast, although FRCs upregulated costimulatory surface receptors, and although they degraded and processed exogenous antigens after myeloablative irradiation, FRCs were dispensable to activate alloreactive CD4+ T cells in 2 mouse models of aGvHD. In summary, these data reveal an immunoprotective, MHCII-mediated function of FRC niches in secondary lymphoid organs (SLOs) after allo-HCT and highlight a framework of cellular and molecular interactions that regulate CD4+ T cell alloimmunity.</abstract><cop>United States</cop><pub>American Society for Clinical Investigation</pub><pmid>36227687</pmid><doi>10.1172/jci.insight.154250</doi><orcidid>https://orcid.org/0000-0001-5257-4776</orcidid><orcidid>https://orcid.org/0000-0001-8551-4729</orcidid><orcidid>https://orcid.org/0000-0002-7680-0819</orcidid><orcidid>https://orcid.org/0000-0001-9193-1772</orcidid><orcidid>https://orcid.org/0000-0001-7143-5691</orcidid><orcidid>https://orcid.org/0000-0001-8071-1379</orcidid><orcidid>https://orcid.org/0000-0002-3165-2648</orcidid><orcidid>https://orcid.org/0000-0002-1954-3641</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2379-3708
ispartof JCI insight, 2022-11, Vol.7 (22)
issn 2379-3708
2379-3708
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_611e9d7a43884ebd9ad1480c9f61f8b7
source PubMed Central
subjects Animals
Graft vs Host Disease - prevention & control
Hematology
Hematopoietic Stem Cell Transplantation - methods
Mice
Mice, Inbred BALB C
Mice, Inbred C57BL
T-Lymphocytes, Regulatory
Transplantation
title Fibroblastic reticular cells mitigate acute GvHD via MHCII-dependent maintenance of regulatory T cells
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-18T12%3A02%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Fibroblastic%20reticular%20cells%20mitigate%20acute%20GvHD%20via%20MHCII-dependent%20maintenance%20of%20regulatory%20T%20cells&rft.jtitle=JCI%20insight&rft.au=Shaikh,%20Haroon&rft.date=2022-11-22&rft.volume=7&rft.issue=22&rft.issn=2379-3708&rft.eissn=2379-3708&rft_id=info:doi/10.1172/jci.insight.154250&rft_dat=%3Cproquest_doaj_%3E2724581762%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c468t-ca5c2d5d69c137ddcadfaca406fb265a546d7b846837fa6b11688b3afe6b026b3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2724581762&rft_id=info:pmid/36227687&rfr_iscdi=true